KindlyMD (NASDAQ:NAKA) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of KindlyMD (NASDAQ:NAKA) from a sell rating to a hold rating in a research note released on Saturday morning,Wall Street Zen reports.

Other equities analysts also recently issued research reports about the company. TD Cowen increased their price target on KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a report on Monday, July 27th. B. Riley Financial boosted their price objective on shares of KindlyMD from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Tuesday, September 22nd. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of KindlyMD in a research note on Wednesday, November 4th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $20.00.

KindlyMD Stock Performance

Shares of NAKA traded down $0.79 during trading hours on Friday, hitting $5.00. 250,561 shares of the company were exchanged, compared to its average volume of 171,962. The company has a market cap of $91.75 million, a PE ratio of -0.33 and a beta of 16.03. The firm’s 50 day moving average is $7.87 and its 200-day moving average is $7.52. KindlyMD has a 52 week low of $3.33 and a 52 week high of $25.22.

KindlyMD (NASDAQ:NAKA) last issued its quarterly earnings data on Friday, November 13th. The company reported $4.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.49) by $4.56. KindlyMD had a negative return on equity of 71.15% and a negative net margin of 1,067.93%. The business had revenue of ($1.93) million for the quarter. As a group, equities analysts forecast that KindlyMD will post -12.94 earnings per share for the current fiscal year.

Insider Activity at KindlyMD

In other KindlyMD news, CEO David F. Bailey acquired 32,134 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average price of $5.59 per share, with a total value of $179,629.06. Following the transaction, the chief executive officer owned 32,134 shares of the company’s stock, valued at approximately $179,629.06. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders bought 41,904 shares of company stock valued at $235,231 in the last 90 days. Insiders own 24.08% of the company’s stock.

KindlyMD Company Profile

KindlyMD is a Utah-based healthcare company that provides outpatient medical services, with a focus on integrated care. Its offerings include primary care, behavioral health and treatment for substance use disorders, along with care coordination intended to connect patients with appropriate services. The company serves patients through clinics in Utah and has emphasized care for people with complex or ongoing health needs. KindlyMD combined with Nakamoto Holdings in 2025; the resulting company trades on Nasdaq under the symbol NAKA.